Christian Leikert
Directeur Général chez Future Capital
Profil
Christian Leikert is currently the Chief Executive Officer at Future Capital, and also holds positions as Director at Blueprint Genetics Oy and Member-Supervisory Board at vasopharm GmbH.
He previously worked as Director at Aegis Analytical Corp., Director at CEVEC Pharmaceuticals GmbH, and Partner at Creathor Venture Management GmbH.
He obtained an MBA from Ludwig-Maximilians-Universität München.
Postes actifs de Christian Leikert
| Sociétés | Poste | Début |
|---|---|---|
Future Capital
 Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Directeur Général | 01/01/2004 |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Directeur/Membre du Conseil | - |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christian Leikert
| Sociétés | Poste | Fin |
|---|---|---|
Creathor Venture Management GmbH
 Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Private Equity Investor | 30/11/2019 |
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Directeur/Membre du Conseil | 01/11/2019 |
Aegis Analytical Corp.
 Aegis Analytical Corp. Packaged SoftwareTechnology Services For more than a decade, Aegis Analytical has provided Enterprise Manufacturing Intelligence solutions that help leading companies such as Abbott Labs, Baxter, Biogen Idec, Cephalon, Eli Lilly, Genzyme, GlaxoSmithKline, Merck Serono and Talecris to realize manufacturing operations excellence. Aegis' Discoverant software solution helps process manufacturers access, aggregate, contextualize and analyze data on-demand from raw materials to final product in both production and process development environments. Discoverant enables customers to accelerate products to market, increase supply chain efficiencies, reduce the cost of new process start-up, quality compliance, improve process predictability and collaboration across captive or outsourced sites. By enabling a laser-like focus on the performance of the manufacturing process itself, Discoverant is the foundation of Enterprise Manufacturing Intelligence and a critical application for initiatives such as Tech Transfer, CMC, Lean, Six Sigma, Continuous Quality Verification and Supply Chain Efficiency. | Directeur/Membre du Conseil | 26/07/2013 |
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Directeur/Membre du Conseil | - |
Formation de Christian Leikert
| Ludwig-Maximilians-Universität München | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Future Capital
Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Finance |
Aegis Analytical Corp.
Aegis Analytical Corp. Packaged SoftwareTechnology Services For more than a decade, Aegis Analytical has provided Enterprise Manufacturing Intelligence solutions that help leading companies such as Abbott Labs, Baxter, Biogen Idec, Cephalon, Eli Lilly, Genzyme, GlaxoSmithKline, Merck Serono and Talecris to realize manufacturing operations excellence. Aegis' Discoverant software solution helps process manufacturers access, aggregate, contextualize and analyze data on-demand from raw materials to final product in both production and process development environments. Discoverant enables customers to accelerate products to market, increase supply chain efficiencies, reduce the cost of new process start-up, quality compliance, improve process predictability and collaboration across captive or outsourced sites. By enabling a laser-like focus on the performance of the manufacturing process itself, Discoverant is the foundation of Enterprise Manufacturing Intelligence and a critical application for initiatives such as Tech Transfer, CMC, Lean, Six Sigma, Continuous Quality Verification and Supply Chain Efficiency. | Technology Services |
CEVEC Pharmaceuticals GmbH
CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Health Technology |
Creathor Venture Management GmbH
Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Finance |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Health Technology |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
